| References |
| 1. |
Allen, D. B., and
B. D. Goldberg.
Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid‐treated children.
Pediatrics
89:
416–421,
1992.
|
| 2. |
Aynsley‐Green, A.,
M. Zachmann, and
A. Prader.
Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism.
J. Pediatr.
89:
992–999,
1976.
|
| 3. |
Baker, J.,
J.‐P. Liu,
E. J. Robertson, and
A. Efistratiadis.
A role of insulin‐like growth factors in embryonic and postnatal growth.
Cell
75:
73–82,
1993.
|
| 4. |
Bates, A. S.,
W. B. Hoff,
P. J. Jones, and
R. N. Clayton.
The effect of hypopituitarism on life expectancy.
J. Clin. Endocrinol. Metab.
81:
1169–1172,
1996.
|
| 5. |
Beck, J. C.,
E. E. McGarry,
I. Dyrenfurth,
R. O. Morgen,
E. D. Bird, and
E. H. Venning.
Primate growth hormone studies in man.
Metabolism
9:
699–737,
1960.
|
| 6. |
Beck, J. C.,
E. E. McGarry,
I. Dyrenfurth, and
E. H. Venning.
Metabolic effects of human and monkey growth hormone in man.
Science
125:
884–885,
1957.
|
| 7. |
Bennet, W. M., and
M. W. Haymond.
Growth hormone and lean tissue catabolism during long‐term glucocorticoid treatment.
Clin. Endocrinol. (Oxf.)
36:
161–164,
1992.
|
| 8. |
Bergenstal, D. M., and
M. B. Lipsett.
Metabolic effects of human growth hormone and growth hormone of other species in man.
J. Clin. Endocrinol. Metab.
20:
1427–1436,
1960.
|
| 9. |
Beshyah, S. A.,
A. Henderson,
R. Niththyananthan,
E. Skinner,
V. Anyaoku,
W. Richmond,
Sharp and
D. G. Johnson.
The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
J. Clin. Endocrinol. Metab.
80:
356–363,
1995.
|
| 10. |
Beshyah, S. A.,
P. S. Sharp,
S. V. Gelding,
S. Halliday, and
D. G. Johnston.
Whole body leucine turnover in adults on conventional treatment for hypopituitarism.
Acta Endocrinol. (Copenh.)
129:
158–164,
1993.
|
| 11. |
Beshyah, S. A.,
E. Thomas,
P. Kyd,
P. Sharp,
A. Fairney, and
D. G. Johnston.
The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
Clin. Endocrinol. (Oxf.)
40:
383–391,
1994.
|
| 12. |
Binnerts, A.,
G. R. Swart,
J. H. Wilson,
N. Hoogerbrugge,
H. A. P. Pols,
J. C. Birkenhager, and
S. W. J. Lamberts.
The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis as well as on body composition.
Clin. Endocrinol. (Oxf.)
37:
79–87,
1992.
|
| 13. |
Blethen, S. L.,
J. Baptista,
J. Kuntze,
T. Foley,
S. LaFranchi, and
A. Johanson.
Adult height in growth hormone (GH)‐deficient children treated with biosynthetic GH.
J. Clin. Endocrinol. Metab.
82:
418–420,
1997.
|
| 14. |
Blodgett, F. M.,
L. Burgin,
D. Iezzoni,
D. Gribetz, and
N. B. Talbot.
Effects of prolonged cortisone treatment on the statural growth, skeletal maturation and metabolic status of children.
N. Engl. J. Med.
254:
636–641,
1956.
|
| 15. |
Bonjour, J. P.,
G. Theintz,
B. Buchs,
D. Slosman, and
R. Rizzoli.
Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence.
J. Clin. Endocrinol. Metab.
73:
555–563,
1991.
|
| 16. |
Bonnet, F.,
M. Vanderschueren‐Lodeweyckx,
R. Eeckels, and
P. Malvaux.
Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone.
Pediatr. Res.
8:
800–805,
1974.
|
| 17. |
Bougneres, P. F.,
E. Artavia‐Loria,
P. Ferre,
J. L. Chaussain, and
J. C. Job.
Effects of hypopituitarism and growth replacement therapy on the production and utilization of glucose in childhood.
J. Clin. Endocrinol. Metab.
61:
1152–1157,
1985.
|
| 18. |
Brent, G.,
J. Harney,
D. Moore, and
P. R. Larsen.
Multihormonal regulation of the human, rat and bovine growth hormone promoters: differential effects of 3′,5′‐cyclic adenosine monophosphate, thyroid hormone and glucocorticoids.
Mol. Endocrinol.
2:
792–796,
1988.
|
| 19. |
Britto, J.,
A. Fenton,
W. Holloway, and
G. C. Nicholson.
Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption.
Endocrinology
134:
169–176,
1994.
|
| 20. |
Brook, C. G. D.
Effect of human growth hormone treatment on adipose tissue in children.
Arch. Dis. Child.
48:
725–728,
1973.
|
| 21. |
Bucher, H.,
H. Zapf,
T. Torresani,
A. Prader,
E. R. Froesch, and
R. Illig.
Insulin‐like growth factors I and II, prolactin and insulin in 19 growth hormone‐deficient children with excessive, normal or decreased longitudinal growth after operation for craniopharyngioma.
N. Engl. J. Med.
309:
1142–1146,
1983.
|
| 22. |
Caron, P. J.,
L. K. Nieman,
S. R. Rose, and
B. C. Nisula.
Deficient nocturnal surge of thyrotropin in central hypothyroidism.
J. Clin. Endocrinol. Metab.
36:
960–964,
1986.
|
| 23. |
Carroll, E. R.,
E. R. Christ, and
the members of Growth Hormone Research Society Scientific Committee.
B. A. Bengtsson,
L. Carlsson,
J. S. Christiansen,
D. Clemmons,
R. Hintz,
K. Ho,
Z. Laron,
P. Sizonenko,
P. H. Sonksen,
T. Tanaka, and
M. Thorner.
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review.
J. Clin Endocrinol. Metab.
83:
382–395,
1998.
|
| 24. |
Carter‐Su, C.,
J. R. Stubbart,
X. Y. Wang,
S. E. Stred,
L. S. Argetsinger, and
J. A. Shafer.
Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor‐associated tyrosine kinase.
J. Biol. Chem.
264:
654–661,
1989.
|
| 25. |
Cheek, D. B.,
J. A. Brasel,
D. Elliott, and
R. Scott.
Muscle cell size and number in normal children and in dwarfs (pituitary, cretins, and primordial) before and after treatment.
Bull. Johns Hopkins Hosp.
119:
46–62,
1966.
|
| 26. |
Chernausek, S. D.,
L. E. Underwood,
R. D. Utiger, and
J. J. Van Wyk.
Growth hormone secretion and plasma somatomedin C in primary hypothyroidism.
Clin. Endocrinol. (Oxf.)
19:
337–344,
1983.
|
| 27. |
Christiansen, J. S.,
J. O. Jorgensen,
S. A. Pedersen,
J. Moller,
J. Jorgensen, and
N. E. Shakkebaek.
Effects of growth hormone on body composition in adults.
Horm. Res.
33
(Suppl. 4):
61–64,
1990.
|
| 28. |
Clark, P. A., and
A. D. Rogol.
Growth hormones and sex steroid interactions at puberty.
Endocrinol. Metab. Clin. North Am.
25:
665–678,
1996.
|
| 29. |
Colle, M., and
J. Auzerie.
Discontinuation of growth hormone therapy in growth‐hormone‐deficient patients: assessment of body fat mass using bioelectrical impedance.
Horm. Res.
39:
192–196,
1993.
|
| 30. |
Conte, F. A.,
M. M. Grumbach, and
Y. Ito.
A syndrome of female pseudohermaphroditism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom.).
J. Clin. Endocrinol. Metab.
78:
1287–1292,
1994.
|
| 31. |
Copeland, K. C., and
K. S. Nair.
Acute growth hormone effects on amino acid metabolism.
J. Clin. Endocrinol. Metab.
78:
1040–1047,
1994.
|
| 32. |
Cuneo, R. C.,
F. Salomon,
G. F. Watts,
R. Hesp, and
P. H. Sonksen.
Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.
Metabolism
42:
1519–1523,
1993.
|
| 33. |
Cuneo, R. C.,
F. Salomon,
C. M. Wiles, and
P. H. Sonksen.
Skeletal muscle performance in adults with growth hormone deficiency.
Horm. Res.
33
(Suppl. 4):
55–60,
1990.
|
| 34. |
Cuneo, R. C.,
F. Salomon,
P. Wilmhurst,
C. Byrne,
C. M. Wiles,
R. Hesp, and
P. H. Sonksen.
Cardiovascular effects of growth hormone treatment in growth hormone deficient adults: stimulation of the renin‐aldosterone system.
Clin. Sci. (Colch.)
81:
587–592,
1991.
|
| 35. |
Cunningham, B. C.,
R. Fukunaga,
S. Nagata,
D. V. Goeddel, and
J. A. Wells.
Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.
Science
254:
821–825,
1991.
|
| 36. |
Davidson, M. B.
Effect of growth hormone on carbohydrate and lipid metabolism.
Endocr. Rev.
8:
115–131,
1987.
|
| 37. |
Deardon, L. C., and
H. D. Mosier.
The effect of prolonged prednisone treatment on human costal cartilage.
Am. J. Pathol.
81:
267–282,
1975.
|
| 38. |
DeBoer, H.,
G.‐J. Blok, and
E. A. V. D. Veen.
Clinical aspects of growth hormone deficiency in adults.
Endocr. Rev.
16:
63–86,
1995.
|
| 39. |
DeBoer, H.,
G. J. Blok,
H. J. Voerman,
M. Philips, and
J. A. Schouten.
Serum lipids in growth hormone deficient men.
Metabolism
43:
199–203,
1994.
|
| 40. |
Degerblad, M.,
O. Almkvist,
R. Grunditz,
K. Hall,
L. Kayser,
E. Knutsson,
H. Ringertz, and
M. Thoren.
Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency.
Acta Endocrinol. (Copenh.)
123:
185–193,
1990.
|
| 41. |
Degerblad, M.,
B.‐A. Bengtsson,
M. Bramnert,
P. Johnell,
P. Manhem,
T. Rosen, and
M. Thoren.
Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.
Eur. J. Endocrinol.
133:
180–188,
1995.
|
| 42. |
Dempsher, D. P.,
D. M. Bier,
S. E. Tollefson,
P. S. Rotwein,
W. H. Daughaday,
M. C. Jensen,
J. P. Galgani,
E. Heath‐Monnig, and
B. Trivedi.
Whole body nitrogen kinetics and their relationship to growth in short children treated with recombinant HGH.
Pediatr. Res.
28:
394–404,
1990.
|
| 43. |
Devoe, D. J.,
W. L. Miller,
F. A. Conte,
S. L. Kaplan,
M. M. Grumbach,
S. M. Rosenthal,
C. B. Wilson, and
S. E. Gitelman.
Longterm outcome in children and adolescents after transsphenoidal surgery for Cushings disease.
J. Clin. Endocrinol. Metab.
82:
3196–3202,
1997.
|
| 44. |
de Zegher, F.,
F. Pernasetti,
C. Vanhole,
H. Devlieger,
G.V.D. Berghe, and
J. A. Martial.
The prenatal role of thyroid hormone evidenced by fetomaternal pit‐1 deficiency.
J. Clin. Endocrinol. Metab.
80:
3127–3130,
1995.
|
| 45. |
Eden, S.,
O. Wiklund,
J. Oscarsson,
T. Rosen, and
B. A. Bengtsson.
Growth hormone treatment of growth hormone deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.
Arterioscler. Thromb. Vasc. Biol.
13:
296–301,
1993.
|
| 46. |
Evans, H. M., and
J. A. Long.
The effect of the anterior lobe of the hypophysis administered intraperitoneally upon growth, and the maturity and oestrus cycles of the rat.
Anat. Rec.
21:
61–63,
1921.
|
| 47. |
Filippi, G., and
V. A. McKusick.
The Beckwith‐Weidemann syndrome.
Medicine
49:
279–298,
1970.
|
| 48. |
Fowden, A. L.,
X. H. Mao, and
R. S. Comline.
The effects of pancreatectomy on the growth and metabolite concentrations of the sheep fetus.
J. Endocrinol.
110:
225–231,
1986.
|
| 49. |
Fowelin, J.,
S. Attvall,
I. Lager, and
B. A. Bengtsson.
Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.
Metabolism
42:
1443–1447,
1993.
|
| 50. |
Frantz, A. G., and
M. T. Rabkin.
Effects of estrogen and sex difference on secretion of human growth hormone.
J. Clin. Endocrinol. Metab.
25:
1470–1480,
1965.
|
| 51. |
Frasier, S. D.
Human pituitary growth hormone therapy in growth hormone deficiency.
Endocr. Rev.
4:
97–130,
1983.
|
| 52. |
Frasier, S. D.,
G. Costin,
B. M. Lippe,
T. Aceto, Jr., and
P. F. Bunger.
A dose‐response curve for human growth hormone.
J. Clin. Endocrinol. Metab.
53:
1213–1217,
1981.
|
| 53. |
Giustina, A., and
W. B. Wehrenberg.
Influence of thyroid hormones on the regulation of growth hormone secretion.
Eur. J. Endocrinol.
133:
646–653,
1995.
|
| 54. |
Glick, S. M.,
J. Roth,
R. S. Yalow, and
S. A. Berson.
Immunoassay of human growth hormone in plasma.
Nature
199:
784–787,
1963.
|
| 55. |
Gluckman, P. D.,
J. H. Butler,
R. Comline, and
A. Fowden.
The effects of pancreatectomy on the plasma concentrations of insulin‐like growth factors 1 and 2 in the sheep fetus.
J. Dev. Physiol.
9:
79–88,
1987.
|
| 56. |
Gluckman, P. D.,
A. J. Gunn,
A. Wray,
W. S. Cutfield,
P. G. Chatelain,
O. Guilbaud,
G. R. Ambler,
P. Wilton, and
K. Albertsson‐Wikland.
Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure.
J. Pediatr.
121:
920–923,
1992.
|
| 57. |
Gluckman, P. D., and
J. E. Harding.
Nutritional and hormonal regulation of fetal growth.
Acta Paediatr. Suppl.
399:
60–63,
1994.
|
| 58. |
Goeddel, D. V.,
H. L. Heyreker,
T. Hozumi,
R. Arentzen,
K. Itakura,
D. G. Yansura,
M. J. Ross,
G. Miozzara,
R. Crea, and
P. H. Seeburg.
Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone.
Nature
281:
544–548,
1979.
|
| 59. |
Goodman, H. G.,
M. M. Grumbach, and
S. L. Kaplan.
Growth and growth hormone II: a comparison of isolated growth hormone deficiency and multiple pituitary hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism.
N. Engl. J. Med.
278:
57–68,
1968.
|
| 60. |
Goodman, H. M.,
Y. Schwartz,
L. R. Tai, and
E. Gorin.
Actions of growth hormone on adipose tissue: possible involvement of autocrine of paracrine factors.
Acta Paediatr. Scand. Suppl.
367:
132–136,
1990.
|
| 61. |
Grumbach, M. M.,
B. S. Bin‐Abbas, and
S. L. Kaplan.
The growth hormone cascade: progress and long‐term results of growth hormone treatment in growth hormone deficiency.
Horm. Res.
(Suppl.)
48:
41–57,
1998.
|
| 62. |
Grumbach, M. M.,
S. L. Kaplan,
C. L. Abrams,
J. J. Bell, and
F. A. Conte.
Plasma free fatty acid response to the administration of chorionic “growth hormone‐prolactin.”
J. Clin. Endocrinol. Metab.
26:
478–482,
1966.
|
| 63. |
Grunfeld, C.,
B. M. Sherman, and
R. R. Cavalieri.
The acute effects of human growth hormone administration on thyroid function in normal men.
J. Clin. Endocrinol. Metab.
67:
1111–1114,
1988.
|
| 64. |
Gurland, G.,
G. Ashcom,
B. H. Cochran, and
J. Schwartz.
Rapid events in growth hormone action: induction of c‐fos and c‐jun transcription in 3T3–F422A adipocytes.
Endocrinology
126:
3187–3195,
1990.
|
| 65. |
Harris, D. A.,
G. V. Vliet,
C. A. Egli,
M. M. Grumbach,
S. L. Kaplan,
D. M. Styne, and
M. Vainsel.
Somatomedin‐C in normal puberty and true precocious puberty before and after treatment with potent luteinizing hormone–releasing hormone agonist.
J. Clin. Endocrinol. Metab.
61:
152–159,
1985.
|
| 66. |
Herndon, D. N.,
R. E. Barrow,
K. R. Kunkel,
L. Broemeling, and
R. L. Rutan.
Effects of recombinant human growth hormone on donor‐site healing in severely burned children.
Ann. Surg.
212:
424–429,
1990.
|
| 67. |
Hershkovitz, E.,
E. Leiberman,
Y. Limony,
S. Shany, and
M. Phillip.
Short‐term growth hormone therapy increases serum lipoprotein(a) levels in normal short children without growth hormone deficiency.
Horm. Res.
46:
38–40,
1996.
|
| 68. |
Hew, F. L.,
M. Koschmann,
T. Krieger, et al:
Insulin tolerance test in patients with anterior pituitary hormone deficiency: reduced insulin sensitivity.
Endocrinol. Metab.
2:
93–98,
1995.
|
| 69. |
Hill, D. E.
Effect of insulin on fetal growth.
Semin. Perinatol.
2:
319–328,
1978.
|
| 70. |
Hill, D. J., and
R.D.G. Milner.
Insulin as a growth factor.
Pediatr. Res.
19:
879–886,
1985.
|
| 71. |
Ho, Y., and
A. J. Weissberger.
The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin‐angiotensin system.
Metabolism
39:
133–137,
1990.
|
| 72. |
Hoffman, D. M.,
L. Crampton,
C. Sernia,
T. V. Nguyen, and
K. K.Y. Ho.
Short term growth hormone (GH) treatment of GH‐deficient adults increases body sodium and extracellular water, but not blood pressure.
J. Clin. Endocrinol. Metab.
81:
1123–1128,1996.
|
| 73. |
Holmes, S. J.,
G. Economou,
R. W. Whitehouse,
J. E. Adams, and
S. M. Shalet.
Reduced bone mineral density in patients with adult onset growth hormone deficiency.
J. Clin. Endocrinol. Metab.
78:
669–674,
1994.
|
| 74. |
Holmes, S. J.,
R. W. Whitehouse,
R. Swindell,
G. Economou,
J. E. Adams, and
S. M. Shalet.
Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency.
Clin. Endocrinol. (Oxf.)
42:
627–633,
1995.
|
| 75. |
Hopwood, N. J.,
P. J. Forsman,
F. M. Kenny, and
A. L. Drash.
Hypoglycemia in hypopituitary children.
Am. J. Dis. Child.
129:
918–929,
1975.
|
| 76. |
Horber, F. F., and
M. W. Haymond.
Human growth hormone prevents the protein catabolic side effects of prednisone in humans.
J. Clin. Invest.
86:
265–272,
1990.
|
| 77. |
Hu, H.‐Y.,
H. Yamamoto,
M. Sohmiya,
T. Abe,
Y. Murakimi, and
Y. Kato.
Body composition assessed by bioeletrical impedance analysis (BIA), and the correlation with plasma insulinlike growth factor 1 in normal Japanese subjects and patients with acromegaly and GH deficiency.
Endocr. J.
41:
63–69,
1994.
|
| 78. |
Hutchings, J. J.,
R. F. Escamilla,
W. C. Deamer, and
C. H. Li.
Metabolic changes produced by human growth hormone (Li) in a pituitary dwarf.
J. Clin. Endocrinol. Metab.
19:
759–769,
1959.
|
| 79. |
Hyer, S. L.,
D. A. Rodin,
J. H. Tobias,
A. Leiper, and
S. S. Nussey.
Growth hormone deficiency during puberty reduces adult bone mineral density.
Arch. Dis. Child.
67:
472–474,
1992.
|
| 80. |
Isaksson, O.G.P.,
A. Lindahl,
A. Nilsson, and
J. Isgaard.
Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth.
Endocr. Rev.
8:
426–438,
1987.
|
| 81. |
Ito, H.,
M. Hiroe,
Y. Hirata,
M. Tsujino,
S. Adachi,
M. Shichiri,
A. Koike,
A. Nogami, and
F. Marum.
Insulin‐like growth factor‐I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes.
Circulation
87:
1715–1721,
1993.
|
| 82. |
Jacob, R.,
E. Barrett,
G. Plewe, and
R. S. Sherwin.
Acute effects of insulin‐like growth factor‐I on glucose and amino acid metabolism in the awake fasted rat.
J. Clin. Invest.
83:
1717–1723,
1989.
|
| 83. |
Johansson, G.,
R. Bjarnason,
M. Bramnert,
L.M.S. Carlsson,
M. Degerblad,
P. Manhem,
T. Rosen,
M. Thoren, and
B.‐A. Bengtsson.
The individual responsiveness to growth hormone (GH) treatment in GH‐deficient adults is dependent on the level of GH‐binding protein, body mass index, age and gender.
J. Clin. Endocrinol. Metab.
81:
1575–1581,
1996.
|
| 84. |
Johansson, J. O.,
K. Landin,
I. Tengborn,
T. Rosen, and
B. A. Bengtsson.
High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults.
Arterioscler. Thromb.
14:
s434–s437,
1994.
|
| 85. |
Johansson, J. O.,
J. Oscarsson,
R. Bjarnason, and
B. A. Bentsson.
Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH‐deficient adults: I. Effects on insulin‐like growth factor‐I(IGF‐I), GH and IGF binding proteins, and glucose homeostasis.
Metabolism
45:
362–369,
1996.
|
| 86. |
Jorgensen, J. O. L.
Human growth hormone replacement therapy: pharmacological and clinical aspects.
Endocr. Rev.
12:
189–207,
1991.
|
| 87. |
Kamel, A.,
V. Margery,
M. Norstedt,
E. Thoren,
A. C. Lindgren,
M. Bronnegard, and
C. Marcus.
Growth hormone (GH) treatment up‐regulates GH receptor mRNA levels in adipocytes from patients with GH deficiency and Prader‐Willi syndrome.
Pediatr. Res.
38:
418–421,
1995.
|
| 88. |
Kaplan, J. G.,
A. T. Moshang, Jr.,
T. Bernstein,
J. S. Parks, and
A. M. Bongiovanni.
Constitutional delay of growth and development. Effects of treatment with androgens.
J. Pediatr.
82:
38–44,
1973.
|
| 89. |
Kaplan, S. L.
The Newer Uses of Growth Hormone in Adults.
Chicago:
Mosby‐Year Book,
1993.
|
| 90. |
Kaplan, S. L.,
G. P. August,
S. L. Blethen,
D. R. Brown,
R. L. Hintz,
A. Johansen,
L. P. Plotnick,
L. E. Underwood,
J. J. Bell,
R. M. Blizzard,
T. P. Foley,
N. J. Hopwood,
R. T. Kirkland,
R. G. Rosenfeld, and
J. J. Van Wyk.
Clinical studies with recombinant DNA‐derived methionyl human growth hormone in growth hormone deficient children.
Lancet
1:
697–700,
1986.
|
| 91. |
Kaplan, S. L., and
M. M. Grumbach.
Clinical review 14. Patho‐physiology and treatment of sexual precocity.
J. Clin. Endocrinol. Metab.
71:
785–789,
1990.
|
| 92. |
Kaplan, S. L.,
M. M. Grumbach,
H. G. Friesen, and
B. H. Costom.
Thyrotropin–releasing factor (TRF) effect on secretion of human pituitary prolactin and thyrotropin in children and in idiopathic hypopituitary dwarfism: further evidence for hypophysiotropic hormone deficiencies.
J. Clin. Endocrinol. Metab.
35:
825–830,
1972.
|
| 93. |
Karlberg, J.,
G. J. Fryer,
I. Engstrom, and
P. Karlberg.
Analysis of linear growth using a mathematical model II. From 3 to 21 years of age.
Acta Paediatr. Scand. Suppl.
337:
12–28,
1987.
|
| 94. |
Katz, H. P.,
R. Youlton,
S. L. Kaplan, and
M. M. Grumbach.
Growth and growth hormone. III. Growth hormone release in children with primary hypothyroidism and thyrotoxicosis.
J. Clin. Endocrinol. Metab.
29:
346–351,
1969.
|
| 95. |
Kaufman, J. M.,
P. Taelman,
A. Vermeulen, and
M. Vandeweghe.
Bone mineral status in growth hormone‐deficient males with isolated and multiple pituitary deficiencies of childhood onset.
J. Clin. Endocrinol. Metab.
74:
118–123,
1992.
|
| 96. |
Kaufman, S.,
K. L. Jones,
W. B. Wehrenberg, and
F. L. Culler.
Inhibition by prednisone of growth hormone (GH) response to GH‐releasing hormone in normal men.
J. Clin. Endocrinol. Metab.
67:
1258–1261,
1988.
|
| 97. |
Kerrigan, J. R., and
A. D. Rogol.
The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence.
Endocr. Rev.
13:
281–298,
1992.
|
| 98. |
Knight, A. B.,
M. M. Rechler,
J. A. Romanus,
E. E. VanObberghen‐Schilling, and
S. P. Nissley.
Stimulation of glucose incorporation and amino acid transport by insulin and an insulin‐like growth factor in fibroblasts with defective insulin receptors cultured from a patient with leprechaunism.
Proc. Natl. Acad. Sci. USA
78:
2554–2558,
1981.
|
| 99. |
Knobil, E., and
R. O. Greep.
The physiology of growth hormone with particular reference to its action in the rhesus monkey and the “species specificity” problem.
Recent Prog. Horm. Res.
15:
1–68,
1959.
|
| 100. |
Li, C. H., and
H. Papkoff.
Preparation and properties of growth hormone from human and monkey pituitary glands.
Science
124:
1293–1294,
1956.
|
| 101. |
Libber, S. M.,
L. P. Plotnick,
A. J. Johanson,
R. M. Blizzard,
P. O. Kwiterovich, and
C. J. Migeon.
Long‐term follow‐up of hypopituitary patients treated with human growth hormone.
Medicine
69:
46–55,
1990.
|
| 102. |
Linderkamp, O.,
O. Butenandt,
T. Mader,
D. Knorr, and
L. P. Riegel.
The effect of growth hormone deficiency and of growth hormone substitution on blood volume and red cell parameters.
Pediatr. Res.
11:
885–889,
1977.
|
| 103. |
Link, K.,
R. M. Blizzard,
W. S. Evans,
D. L. Kaiser,
M. W. Parker, and
A. D. Rogol.
The effect of androgens on the pulsatile release and the twenty‐four‐hour mean concentration of growth hormone in peripubertal males.
J. Clin. Endocrinol. Metab.
62:
159–164,
1986.
|
| 104. |
Lippe, B. M.,
S. A. Kaplan,
M. P. Golden,
S. A. Hendricks, and
M. L. Scott.
Carbohydrate tolerance and insulin receptor binding in children with hypopituitarism: responses after acute and chronic human growth hormone administration.
J. Clin. Endocrinol. Metab.
53:
507–513,
1981.
|
| 105. |
LoCasio, V.,
E. Bonnucci,
B. Imbimbo,
P. Ballanti,
S. Adami,
S. Milani,
D. Tartarotti, and
C. DellaRocca.
Bone loss in response to long‐term glucocorticoid therapy.
Bone Miner.
8:
39–51,
1990.
|
| 106. |
Lovinger, R. D.,
S. L. Kaplan, and
M. M. Grumbach.
Congenital hypopituitarism associated with neonatal hypoglycemia and microphallus: four cases secondary to hypothalamic deficiencies.
J. Pediatr.
87:
1171–1181,
1975.
|
| 107. |
Maes, M.,
J. M. Ketelslegers, and
L. E. Underwood.
Low plasma somatomedin‐C in streptozotocin‐induced diabetes mellitus.
Diabetes
32:
1060–1069,
1983.
|
| 108. |
Malhotra, A.,
E. Poon,
W.‐Y. Tse,
P. J. Pringle,
P. C. Hindmarsh, and
C. G. D. Brook.
The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.
Clin. Endocrinol.
38:
393–398,
1993.
|
| 109. |
Mansfield, M. J.,
C. R. Rudlin,
J. F. Crigler,
K. A. Karol,
J. D. Crawford,
P. A. Boepple, and
W. F. Crowley, Jr.
Changes in growth and serum growth hormone and plasma somatomedin‐C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
J. Clin. Endocrinol. Metab.
66:
3–9,
1988.
|
| 110. |
Markussis, V.,
S. A. Beshyah,
C. Fisher,
P. Sharp,
A. N. Nicolaides, and
D. G. Johnston.
Detection of premature atherosclerosis by high‐resolution ultrasonography in symptom‐free hypopituitary adults.
Lancet
340:
1188–1192,
1992.
|
| 111. |
Martha, Jr., P. M.,
A. D. Rogol,
J. D. Veldhuis,
J. R. Kerrigan,
D. W. Goodman, and
R. M. Blizzard.
Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys.
J. Clin. Endocrinol. Metab.
69:
563–570,
1989.
|
| 112. |
Mauras, N.
Combined recombinant human growth hormone and recombinant IGF‐1: lack of synergy on whole body protein metabolism in normally fed subjects.
J. Clin. Endocrinol. Metab.
80:
2633–2637,
1995.
|
| 113. |
Mauras, N.,
F. F. Horber, and
M. W. Haymond.
Low dose recombinant human insulin‐like growth factor‐1 fails to affect protein anabolism but inhibits islet cell secretion in humans.
J. Clin. Endocrinol. Metab.
75:
1192–1197,
1992.
|
| 114. |
Mauras, N.,
T. Merimee, and
A. D. Rogol.
Function of the growth hormone–insulin‐like growth factor‐I axis in the profoundly growth‐retarded diabetic child: evidence for defective target organ responsiveess in the Mauriac syndrome.
Metabolism
40:
1106–1111,
1991.
|
| 115. |
Mauras, N.,
A. D. Rogol, and
J. D. Veldhuis.
Increased hGH production rate after low‐dose estrogen therapy in prepubertal girls with Turner's syndrome.
Pediatr. Res.
28:
626,
1990.
|
| 116. |
Menon, R. K., and
M. A. Sperling.
Insulin as a growth factor.
Endocrinol. Metab. Clin. North Am.
25:
633–647,
1996.
|
| 117. |
Merimee, T. J.
A follow‐up study of vascular disease in growth‐deficient dwarfs with diabetes.
N. Engl. J. Med.
298:
1217–1222,
1978.
|
| 118. |
Merimee, T. J.,
S. E. Fineberg, and
W. Hollander.
Vascular disease in the chronic HGH‐deficient state.
Diabetes
22:
813–819,
1973.
|
| 119. |
Merimee, T. J.,
S. E. Fineberg, and
J. W. Tyson.
Fluctuations of human growth hormone during menstrual cycle. Response to arginine.
Metabolism
18:
606–608,
1969.
|
| 120. |
Merimee, T. J.,
W. Hollander, and
S. E. Fineberg.
Studies of hyperlipidaemia in hGH deficient state.
Metabolism
21:
1053–1061,
1972.
|
| 121. |
Merola, B.,
A. Cittadini,
A. Colao,
S. Longobardi,
S. Fazio,
D. Sabatini,
L. Sacca, and
G. Lombardi.
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency.
J. Clin. Endocrinol. Metab.
77:
1658–1661,
1993.
|
| 122. |
Metzger, D. L., and
J. R. Kerrigan.
Androgen receptor blockade with flutamide enhances growth hormone secretion in late pubertal males: evidence for independent actions of estrogen and androgen.
J. Clin. Endocrinol. Metab.
76:
1147–1152,
1993.
|
| 123. |
Metzger, D. L., and
J. R. Kerrigan.
Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence.
J. Clin. Endocrinol. Metab.
79:
513–518,
1994.
|
| 124. |
Moller, D. E., and
J. S. Flier.
Insulin resistance—mechanisms, syndromes and implications.
N. Engl. J. Med.
325:
938–948,
1991.
|
| 125. |
Moller, J.,
I. Frandsen,
S. Fisker,
J. O. L. Jorgensen, and
J. S. Christiansen.
Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study.
Clin. Endocrinol. (Oxf.)
44:
533–539,
1996.
|
| 126. |
Morishima, A.,
M. M. Grumbach,
E. R. Simpson,
C. Fisher, and
K. Qin.
Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.
J. Clin. Endocrinol. Metab.
80:
3689–3698,
1995.
|
| 127. |
Morris, H. G.
Growth and skeletal maturation in asthmatic children: effect of corticosteroid treatment.
Pediatr. Res.
9:
579–583,
1975.
|
| 128. |
Morris, H. G.,
J. R. Jorgensen,
H. Elrick,
R. E. Goldsmith, and
V. L. Subyan.
Metabolic effects of human growth hormone in corticoid‐treated children.
J. Clin. Invest.
47:
436–451,
1968.
|
| 129. |
Municchi, G.,
S. Malozowski,
B. C. Nisula,
A. Cristiano, and
S. R. Rose.
Nocturnal thyrotropin surge in growth hormone‐deficient children.
J. Pediatr.
121:
214–220,
1992.
|
| 130. |
Murphy, L. J.,
G. I. Bell, and
H. G. Friesen.
Growth hormone stimulates sequential induction of c‐myc and insulin‐like growth factor I expression in vivo.
Endocrinology
120:
1806–1812,
1987.
|
| 131. |
Nakagawa, K.,
T. Ishizuka,
T. Obara,
M. Matsubara, and
K. Akikawa.
Dichotomic action of gluccorticoids on growth hormone secretion.
Acta Endocrinol. (Copenh.)
116:
165–171,
1987.
|
| 132. |
Nass, R.,
R. M. Huber,
V. Klauss,
O. A. Muller,
J. Schopohl, and
C. J. Strasburger.
Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patient with hGH deficiency acquired in adulthood.
J. Clin. Endocrinol. Metab.
80:
552–557,
1995.
|
| 133. |
O'Halloran, D. J.,
A. Tsatsiykus,
R. W. Whitehouse,
S.J. Holmes,
J. E. Adams, and
S. M. Shalet.
Increased bone density after recombinant human growth hormone (GH) in adults with isolated GH deficiency.
J. Clin. Endocrinol. Metab.
76:
1344–1348,
1993.
|
| 134. |
O'Neal, D.,
R. L. Hew,
K. Sikaris,
G. Ward,
F. Alford, and
J. S. Best.
Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.
J. Clin. Endocrinol. Metab.
81:
2448–2454,
1996.
|
| 135. |
Oikarinen, A.
Effect of Cortisol acetate on collagen biosynthesis and on the activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyl transferase and collagen glucosyltransferase in chick‐embryo tendon cells.
Biochem J.
64:
533–539,
1977.
|
| 136. |
Ott, S. M.,
Editorial.
Attainment of peak bone mass.
J. Clin. Endocrinol. Metab.
71:
1082A–1082C,
1990.
|
| 137. |
Pedersen, J.
Weight and length at birth of infants of diabetic mothers.
Acta Endocrinol. (Copenh.)
16:
330–342,
1954.
|
| 138. |
Phillips, L. S.,
A. C. Herington,
I. E. Karl, and
W. H. Daughaday.
Comparison of somatomedin activity in perfusates of normal and hypophysectomized rat livers with and without added growth hormone.
Endocrinology
98:
606–614,
1976.
|
| 139. |
Plotnick, L. P.,
R. G. Thompson,
I. Beitins, and
R. M. Blizzard.
Integrated concentrations of growth hormone correlated with stage of puberty and estrogen levels in girls.
J. Clin. Endocrinol. Metab.
38:
436–439,
1974.
|
| 140. |
Raben, M. S.
Treatment of a pituitary dwarf with human growth hormone.
J. Clin. Endocrinol. Metab.
18:
901–903,
1958.
|
| 141. |
Raben, M. S.
Human growth hormone.
Recent Prog. Horm. Res.
15:
71–74,
1959.
|
| 142. |
Raben, M. S., and
C. H. Hollenberg.
Effect of growth hormone on plasma fatty acids.
J. Clin. Invest.
38:
484–488,
1958.
|
| 143. |
Rabson, S. M., and
E. N. Mendenhall.
Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus: report of 3 cases.
Am. J. Clin. Pathol.
26:
283–290,
1956.
|
| 144. |
Ranke, M. B.,
D. A. Price,
K. Albertson‐Wikland,
M. Maes, and
A. Lindberg.
Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency.
Horm. Res.
48:
62–71,
1997.
|
| 145. |
Rezvani, I.,
A. M. DiGeorge,
S. A. Dowshen, and
C. J. Bourdony.
Action of human growth hormone (hGH) on extrathyroidal conversion of thyroxine (T4) to triiodothyronine (T3) in children with hypopituitarism.
Pediatr. Res.
15:
6–9,
1981.
|
| 146. |
Ristelli, J.
Effect of prednisolone on the activities of intracellular enzymes of collagen biosynthesis in rat liver and skin.
Biochem. Pharmacol.
26:
1295–1298,
1977.
|
| 147. |
Rivkees, S. A.,
M. Danon, and
J. Herrin.
Prednisone dose limitation of growth hormone treatment of steroid‐induced growth failure.
J. Pediatr.
125:
322–325,
1994.
|
| 148. |
Root, A. W.,
A. M. Bongiovanni, and
W. R. Eberlein.
Inhibition of thyroidal radioiodine uptake by human growth hormone.
J. Pediatr.
76:
422–429,
1970.
|
| 149. |
Root, A. W.,
P. J. Snyder,
I. Rezvani,
A. M. D. George, and
R. D. Utiger.
Inhibition of thyrotropin–releasing hormone‐mediated secretion of thyrotropin by human growth hormone.
J. Clin. Endocrinol. Metab.
36:
103–107,
1973.
|
| 150. |
Rose, S. R.
Isolated central hyothyroidism in short stature.
Pediatr. Res.
38:
967–973,
1995.
|
| 151. |
Rose, S. R.,
P. K. Manasco,
S. Pearce, and
B. C. Nisula.
Hypothyroidism and deficiency of the nocturnal thyrotropin surge in children with hypothalamic–pituitary disorders.
J. Clin. Endocrinol. Metab.
70:
1750–1755,
1990.
|
| 152. |
Rose, S. R.,
G. Municchi,
K. M. Barnes,
G. A. Kamp,
M. M. Uriarte,
J. L. Ross,
F. Cassorla, and
G. B. Cutler, Jr.
Spontaneous growth hormone secretion increases during puberty in normal boys and girls.
J. Clin. Endocrinol. Metab.
73:
428–435,
1991.
|
| 153. |
Rosen, T., and
B. A. Bengtsson.
Premature mortality due to cardiovascular disease in hypopituitarism.
Lancet
336:
285–288,
1990.
|
| 154. |
Rosen, T.,
S. Eden,
G. Larson,
L. Wilhelmsen, and
B. A. Bengtsson.
Cardiovascular risk factors in adult patients with growth hormone deficiency.
Acta Endocrinol. (Copenh.)
129:
195–200,
1993.
|
| 155. |
Rosen, T.,
T. Hansson,
H. Granhed,
J. Szucs, and
B. A. Bengtsson.
Reduced bone mineral content in adult patients with growth hormone deficiency.
Acta Endocrinol. (Copenh.)
129:
201–206,
1993.
|
| 156. |
Roupas, P.,
S. Y. Chou,
R. J. Towns, and
J. L. Kostyo.
Growth hormone inhibits activation of phosphatidylinositol phospholipase C in adipose plasma membranes: evidence for a growth hormone‐induced change in G protein function.
Proc. Natl. Acad. Sci. USA
88:
1691–1695,
1991.
|
| 157. |
Russel‐Jones, D. L.,
A. J. Weissberger,
S. B. Bowes,
J. M. Kelly,
M. Thomason,
A. M. Umpleby,
R. H. Jones, and
P. H. Sonksen.
The effects of growth hormone on protein metabolism in adult growth hormone deficient patients.
Clin. Endocrinol. (Oxf.)
38:
427–431,
1993.
|
| 158. |
Rutherford, O. M.,
D. A. Jones,
J. M. Round,
C. R. Buchanan, and
M. A. Preece.
Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults.
Clin. Endocrinol. (Oxf.)
34:
469–475,
1991.
|
| 159. |
Sadeghi‐Nejad, A., and
B. Senior.
Adrenal function, growth, and insulin in patients treated with corticoids on alternate days.
Pediatrics
43:
277–283,
1969.
|
| 160. |
Saenger, P.,
K. A. Attie,
J. DiMartino‐Nardi,
R. N. Fine, and
the Genentech Group:
Carbohydrate metabolism in children receiving growth hormone for 5 years.
Pediatr. Nephrol.
10:
261–263,
1996.
|
| 161. |
Saggese, G.,
G. I. Baroncelli,
S. Bertelloni, and
S. Barsanti.
The effect of long‐term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
J. Clin. Endocrinol. Metab.
81:
3077–3083,
1996.
|
| 162. |
Saggese, G.,
G. I. Baroncelli,
S. Bertelloni,
L. Cinquanta, and
G. D. Nero.
Effects of long‐term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
J. Pediatr.
122:
37–45,
1993.
|
| 163. |
Salomon, F.,
R. C. Cuneo,
R. Hesp, and
P. H. Sonksen.
The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.
N. Engl. J. Med.
321:
1797–1803,
1989.
|
| 164. |
Salter, J., and
C. H. Best.
Insulin as a growth hormone.
BMJ
2:
353–356,
1953.
|
| 165. |
Sato, T.,
Y. Suzuki,
R. Taketani,
K. Ishiguro,
T. Masuyama,
I. Takata,
M. Sano,
H. Kawashima,
S. Koizumi, and
H. Nakajima.
Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children.
J. Clin. Endocrinol. Metab.
45:
324–329,
1977.
|
| 166. |
Schilling, E. E.,
M. M. Rechler,
C. Grunfeld, and
A. M. Rosenberg.
Primary defect of insulin receptors in skin fibroblasts cultured from an infant with leprechaunism and insulin resistance.
Proc. Natl. Acad. Sci. USA
76:
5877–5881,
1979.
|
| 167. |
Shore, R. M.,
R. B. Mazess, and
F. J. Bargman.
Bone mineral status in growth hormone deficiency.
J. Pediatr.
96:
393–396,
1980.
|
| 168. |
Smith, E. P.,
J. Boyd,
G. R. Frank,
H. Takahashi,
R. M. Cohen,
B. Specker,
T. C. Williams,
D. B. Lubahn, and
K. S. Korach.
Estrogen resistance caused by a mutation in the estrogen‐receptor gene in a man.
N. Engl. J. Med.
331:
1056–1061,
1994.
|
| 169. |
Smith, P. E.
Hypophysectomy and replacement therapy in the rat.
Am. J. Anat.
45:
205–273,
1930.
|
| 170. |
Snel, Y.E.M.,
M. E. Doerga,
R. J. Brummer,
P.M.J. Zelissen, and
H.P.F. Koppeschaar.
Magnetic resonance imaging‐assessed adipose tissue and serum lipid and insulin concentrations in growth hormone‐deficient adults. Effect of growth hormone replacement.
Arterioscler Thromb. Vasc. Biol.
15:
1543–1547,
1995.
|
| 171. |
Tamborlane, W. V.,
M. Genel,
S. Gianfredi, and
J. M. Gertner.
The effect of small but sustained elevations in circulating growth hormone on fuel metabolism in growth hormone deficiency.
Pediatr. Res.
18:
212–215,
1984.
|
| 172. |
Tanner, J. M., and
R. H. Whitehouse.
The effect of human growth hormone on subcutaneous fat thickness in hyposomatotrophic and panhypopituitary dwarfs.
J. Endocrinol.
39:
263–275,
1967.
|
| 173. |
Tanner, J. M.,
R. H. Whitehouse,
P. C. R. Hughes, and
B. S. Carter.
Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone‐deficient children.
J. Pediatr.
89:
1000–1008,
1976.
|
| 174. |
Taylor, S. I.,
J. A. Hedo,
L. H. Underhill,
M. Kasuga,
M. J. Elders, and
J. Roth.
Extreme insulin resistance in association with abnormally high binding affinity of insulin receptors from a patient with leprechaunism: evidence for a defect intrinsic to the receptor.
J. Clin. Endocrinol. Metab.
55:
1108–1113,
1982.
|
| 175. |
Theintz, G.,
B. Buchs,
R. Rizzoli,
D. Slosman,
H. Clavien,
P. C. Sizonenko, and
J. P. Bonjour.
Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.
J. Clin. Endocrinol. Metab.
75:
1060–1065,
1992.
|
| 176. |
Vandeweghe, M.,
P. Taelman, and
J. M. Kaufman.
Short and long‐term effects of growth hormone therapy on bone turnover and bone mineral content in adult growth hormone‐deficient males.
Clin. Endocrinol. (Oxf.)
39:
409–415,
1993.
|
| 177. |
von Muhlendahl, K. E., and
H. Herkenhoff.
Long‐term course of neonatal diabetes.
N. Engl. J. Med.
333:
704–708,
1995.
|
| 178. |
Whitehead, H. M.,
J. S. Gilliland,
O. V. Allem, and
D. R. Hadden.
Growth hormone treatment in adults with growth hormone deficiency: effect on muscle fibre size and proportions.
Acta Paediatr. Scand. Suppl.
356:
65–67,
1989.
|
| 179. |
Wilkins, L.
Epiphyseal dysgenesis associated with hypothyroidism.
Am. J. Dis. Child.
61:
13–34,
1941.
|
| 180. |
Winter, R. J.,
R. G. Thompson, and
O. C. Green.
Serum cholesterol and triglycerides in children with growth hormone deficiency.
Metabolism
28:
1244–1249,
1979.
|
| 181. |
Yarasheski, K. E.,
J. R. Campbell,
K. Smith,
M. J. Rennie,
J. O. Holloszy, and
D. M. Bier.
Effect of growth hormone and resistant exercise on muscle growth in young men.
Am. J. Physiol.
262
(Endocrinol. Metab.
E261–E267,
1992).
|
| 182. |
Ziegler, T. R.,
J. L. Rombeau,
L. S. Young,
Y. Jong,
M. Marano,
S. F. Lowry, and
D. W. Wilmore.
Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double‐blind randomized controlled study.
J. Clin. Endocrinol. Metab.
74:
865–873,
1992.
|
